tiprankstipranks
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
GLUE
Monte Rosa Therapeutics
RESEARCH TOOLSreports
Want to see GLUE full AI Analyst Report?

Monte Rosa Therapeutics (GLUE) Financial Statements

381 Followers

Monte Rosa Therapeutics Financial Overview

Monte Rosa Therapeutics's market cap is currently $1.46B. The company's EPS TTM is $-0.54; its P/E ratio is -33.72; Monte Rosa Therapeutics is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 123.67M$ 75.62M$ 0.00$ 0.00$ 0.00
Gross Profit$ 115.32M$ 67.50M$ -6.22M$ -8.56M$ 0.00
Operating Income$ -54.21M$ -81.11M$ -143.31M$ -112.38M$ -72.88M
EBITDA$ -45.85M$ -72.99M$ -137.09M$ -108.64M$ -70.75M
Net Income$ -38.63M$ -72.70M$ -135.35M$ -108.50M$ -73.96M
Balance Sheet
Cash & Short-Term Investments$ 377.10M$ 372.15M$ 232.41M$ 262.83M$ 346.07M
Total Assets$ 448.66M$ 438.73M$ 303.75M$ 342.39M$ 366.33M
Total Debt$ 39.19M$ 42.72M$ 46.04M$ 47.00M$ 0.00
Net Debt$ -90.69M$ -181.54M$ -82.06M$ -7.91M$ -346.07M
Total Liabilities$ 215.60M$ 215.80M$ 124.50M$ 70.98M$ 18.81M
Stockholders' Equity$ 233.06M$ 222.94M$ 179.25M$ 271.41M$ 347.51M
Cash Flow
Free Cash Flow$ -27.50M$ 38.01M$ -62.84M$ -105.38M$ -69.09M
Operating Cash Flow$ -22.80M$ 42.00M$ -43.80M$ -92.47M$ -59.36M
Investing Cash Flow$ -101.83M$ -44.45M$ 88.80M$ -219.22M$ -9.65M
Financing Cash Flow$ 30.35M$ 98.89M$ 27.49M$ 20.47M$ 377.56M
Currency in USD

Monte Rosa Therapeutics Earnings and Revenue History

Income Statement >

Monte Rosa Therapeutics Debt to Assets

Balance Sheet >

Monte Rosa Therapeutics Cash Flow

Cash Flow >

Monte Rosa Therapeutics Forecast EPS vs Actual EPS

Earnings >